Crossmark

Research interrupted: applying the CONSERVE 2021 Statement to a randomized trial of rehabilitation during critical illness affected by the COVID-19 pandemic

Crossref DOI link: https://doi.org/10.1186/s13063-022-06640-y

Published Online: 2022-09-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Reid, Julie C. https://orcid.org/0000-0002-1424-3105
Molloy, Alex

Strong, Geoff

Kelly, Laurel

O’Grady, Heather

Cook, Deborah

Archambault, Patrick M.

Ball, Ian

Berney, Sue

Burns, Karen E. A.

D’Aragon, Frederick

Duan, Erick

English, Shane W.

Lamontagne, François

Pastva, Amy M.

Rochwerg, Bram

Seely, Andrew J. E.

Serri, Karim

Tsang, Jennifer L. Y.

Verceles, Avelino C.

Reeve, Brenda

Fox-Robichaud, Alison

Muscedere, John

Herridge, Margaret

Thabane, Lehana

Kho, Michelle E.

,
Funding

Funding for this research was provided by:

Canada Foundation for Innovation (228975)

Canadian Institutes of Health Research (PJT-155919)
License Information

Text and Data Mining valid from 2022-09-02

Version of Record valid from 2022-09-02
More Information

Article History

Received: 10 November 2021

Accepted: 6 August 2022

First Online: 2 September 2022

Declarations

:

: This study has been approved by the Hamilton Integrated Research Ethics Board (HiREB) for all Hamilton study sites, by Clinical Trials Ontario for all Ontario, Canada study sites, and by all other sites’ local ethics committees. Participation in this study is voluntary and participants provide informed consent.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below